Hypertension among people living with human immunodeficiency virus in sub-Saharan Africa: a systematic review and meta-analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 Jul 2024
Historique:
received: 09 12 2023
accepted: 15 07 2024
medline: 23 7 2024
pubmed: 23 7 2024
entrez: 22 7 2024
Statut: epublish

Résumé

We performed a systematic review and meta-analysis of hypertension in people living with human immunodeficiency virus (HIV) in sub-Saharan Africa (SSA). We searched the PubMed, Google Scholar, African Index Medicus, and Embase databases to identify studies published from January 1, 2010, to December 31, 2021. We used a random-effects model to estimate the pooled prevalence of hypertension and mean SBP/DBP level on a sex-specific basis. We included 48 studies reporting data on a pooled sample of 193,843 people living with HIV (PLW-HIV) in SSA. The pooled mean SBP/DBP level was 120 (95% CI 113-128)/77 (95%CI 72-82) mmHg, while the overall pooled prevalence of hypertension was 21.9% (95% CI 19.9-23.9%). Further meta-regression analyses suggested that the prevalence of hypertension was 1.33 times greater in males, 1.23 times greater in individuals receiving antiretroviral therapy (ART) and 1.45 times greater in those individuals with a CD4-count ≥ 200. This meta-analysis of the contemporary pattern of BP levels among PLW-HIV in SSA, suggests that around one in five of such individuals also have hypertension. Given the further context of greater access to ART and subsequently greater longevity, study findings support calls to integrate cardiovascular management into routine HIV care.

Identifiants

pubmed: 39039244
doi: 10.1038/s41598-024-67703-5
pii: 10.1038/s41598-024-67703-5
doi:

Types de publication

Journal Article Systematic Review Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

16858

Subventions

Organisme : National Health and Medical Research Council of Australia
ID : GNT1135894

Informations de copyright

© 2024. The Author(s).

Références

Nsanzimana, S. & Mills, E. J. Estimating HIV incidence in sub-Saharan Africa. Lancet HIV 10(3), e146–e148 (2023).
pubmed: 36702150 doi: 10.1016/S2352-3018(22)00366-6
Palacios, R. et al. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients: A prospective study in a cohort of naive patients. HIV Med. 7(1), 10–15 (2006).
pubmed: 16313287 doi: 10.1111/j.1468-1293.2005.00333.x
Okello, S. et al. Association between HIV and blood pressure in adults and role of body weight as a mediator: Cross-sectional study in Uganda. J. Clin. Hypertens. (Greenwich) 19(11), 1181–1191 (2017).
pubmed: 28895288 doi: 10.1111/jch.13092
Dobe, I. et al. Patterns of cardiovascular risk and disease in HIV-positive adults on anti-retroviral therapy in Mozambique. Cardiovasc. J. Afr. 31(4), 190–195 (2020).
pubmed: 32634198 doi: 10.5830/CVJA-2020-007
Isaac Derick, K. & Khan, Z. Prevalence, awareness, treatment, control of hypertension, and availability of hypertension services for patients living with human immunodeficiency virus (HIV) in Sub-Saharan Africa (SSA): A systematic review and meta-analysis. Cureus 15(4), e37422 (2023).
pubmed: 37182060 pmcid: 10173023
Chen, A. et al. Elevated blood pressure among adolescents in sub-Saharan Africa: A systematic review and meta-analysis. Lancet Glob. Health 11(8), e1238–e1248 (2023).
pubmed: 37474231 doi: 10.1016/S2214-109X(23)00218-8
Guwatudde, D. et al. The burden of hypertension in sub-Saharan Africa: A four-country cross sectional study. BMC Public Health 15, 1211 (2015).
pubmed: 26637309 pmcid: 4670543 doi: 10.1186/s12889-015-2546-z
Keates, A. K. et al. Cardiovascular disease in Africa: Epidemiological profile and challenges. Nat. Rev. Cardiol. 14(5), 273–293 (2017).
pubmed: 28230175 doi: 10.1038/nrcardio.2017.19
da Cunha, J. et al. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs. World J. Virol. 4(2), 56–77 (2015).
pubmed: 25964872 pmcid: 4419122 doi: 10.5501/wjv.v4.i2.56
Stewart, S. et al. The clinical consequences and challenges of hypertension in urban-dwelling black Africans: Insights from the Heart of Soweto Study. Int. J. Cardiol. 146(1), 22–27 (2011).
pubmed: 19560221 doi: 10.1016/j.ijcard.2009.05.061
Sliwa, K. et al. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur. Heart J. 33(7), 866–874 (2012).
pubmed: 22048682 doi: 10.1093/eurheartj/ehr398
Thienemann, F. et al. The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry. Int. J. Cardiol. 221, 205–211 (2016).
pubmed: 27404676 doi: 10.1016/j.ijcard.2016.06.242
Kanters, S. et al. Evidence synthesis evaluating body weight gain among people treating HIV with antiretroviral therapy—A systematic literature review and network meta-analysis. EClinicalMedicine 48, 101412 (2022).
pubmed: 35706487 pmcid: 9112095 doi: 10.1016/j.eclinm.2022.101412
Hoy, D. et al. Assessing risk of bias in prevalence studies: Modification of an existing tool and evidence of interrater agreement. J. Clin. Epidemiol. 65(9), 934–939 (2012).
pubmed: 22742910 doi: 10.1016/j.jclinepi.2011.11.014
Kharsany, A. B. & Karim, Q. A. HIV infection and AIDS in Sub-Saharan Africa: Current status. Chall. Opportun. Open AIDS J. 10, 34–48 (2016).
doi: 10.2174/1874613601610010034
Page, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).
pubmed: 33782057 pmcid: 8005924 doi: 10.1136/bmj.n71
Amare, H. et al. Predictors of glucose metabolism and blood pressure among Ethiopian individuals with HIV/AIDS after one-year of antiretroviral therapy. Trop. Med. Int. Health 26(4), 428–434 (2021).
pubmed: 33405245 doi: 10.1111/tmi.13544
Ataro, Z. et al. Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia. HIV AIDS (Auckl) 10, 181–192 (2018).
pubmed: 30349400 pmcid: 6190641
Bengtson, A. M. et al. High blood pressure at entry into antenatal care and birth outcomes among a cohort of HIV-uninfected women and women living with HIV initiating antiretroviral therapy in South Africa. Pregnancy Hypertens. 23, 79–86 (2021).
pubmed: 33285444 doi: 10.1016/j.preghy.2020.11.005
Benzekri, N. A. et al. Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994–2015. PLoS One 13(12), e0208635 (2018).
pubmed: 30596667 pmcid: 6312281 doi: 10.1371/journal.pone.0208635
Bloomfield, G. S. et al. Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS One 6(7), e22288 (2011).
pubmed: 21779407 pmcid: 3136516 doi: 10.1371/journal.pone.0022288
Brennan, A. T. et al. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa. PLoS One 13(10), e0204020 (2018).
pubmed: 30281618 pmcid: 6169897 doi: 10.1371/journal.pone.0204020
Chepchirchir, A., Jaoko, W. & Nyagol, J. Risk indicators and effects of hypertension on HIV/AIDS disease progression among patients seen at Kenyatta hospital HIV care center. AIDS Care 30(5), 544–550 (2018).
pubmed: 28990417 doi: 10.1080/09540121.2017.1384533
Chiwandire, N. et al. Trends, prevalence and factors associated with hypertension and diabetes among South African adults living with HIV, 2005–2017. BMC Public Health 21(1), 462 (2021).
pubmed: 33676478 pmcid: 7937211 doi: 10.1186/s12889-021-10502-8
Dimala, C. A. et al. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) compared with HAART-naive patients at the Limbe Regional Hospital, Cameroon. PLoS One 11(2), e0148100 (2016).
pubmed: 26862763 pmcid: 4749660 doi: 10.1371/journal.pone.0148100
Diouf, A. et al. Diabetes and hypertension among patients receiving antiretroviral treatment since 1998 in Senegal: Prevalence and associated factors. ISRN AIDS 2012, 621565 (2012).
pubmed: 24052880 pmcid: 3767342 doi: 10.5402/2012/621565
Divala, O. H. et al. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: Consequences for integrated services. BMC Public Health 16(1), 1243 (2016).
pubmed: 27955664 pmcid: 5153818 doi: 10.1186/s12889-016-3916-x
Dzudie, A. et al. Hypertension among people living with HIV/AIDS in Cameroon: A cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS. PLoS One 16(7), e0253742 (2021).
pubmed: 34292956 pmcid: 8297808 doi: 10.1371/journal.pone.0253742
Fiseha, T. et al. Hypertension in HIV-infected patients receiving antiretroviral therapy in northeast Ethiopia. Int. J. Hypertens. 2019, 4103604 (2019).
pubmed: 31929895 pmcid: 6942833 doi: 10.1155/2019/4103604
Gebrie, A. Hypertension among people living with human immunodeficiency virus receiving care at referral hospitals of Northwest Ethiopia: A cross-sectional study. PLoS One 15(8), e0238114 (2020).
pubmed: 32822432 pmcid: 7446815 doi: 10.1371/journal.pone.0238114
Getahun, Z. et al. Comorbidity of HIV, hypertension, and diabetes and associated factors among people receiving antiretroviral therapy in Bahir Dar city, Ethiopia. J. Comorb. 10, 2235042X19899319 (2020).
Gonah, L., Moodley, I. & Hlongwana, K. Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe. Afr. J. Prim. Health Care Fam. Med. 12(1), e1–e6 (2020).
pubmed: 33181877 doi: 10.4102/phcfm.v12i1.2473
Hoffman, R. M. et al. High rates of uncontrolled blood pressure in Malawian adults living with HIV and hypertension. Glob. Heart 16(1), 81 (2021).
pubmed: 34909372 pmcid: 8663744 doi: 10.5334/gh.1081
Isa, S. E. et al. Hypertension in treated and untreated patients with HIV: a study from 2011 to 2013 at the Jos University Teaching Hospital, Nigeria. Trans. R Soc. Trop. Med. Hyg. 111(4), 172–177 (2017).
pubmed: 28673018 pmcid: 6257023 doi: 10.1093/trstmh/trx030
Kalyesubula, R. et al. Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, Uganda: A retrospective study. BMJ Glob. Health 1(3), e000055 (2016).
pubmed: 28588953 pmcid: 5321354 doi: 10.1136/bmjgh-2016-000055
Kasper, P. et al. 24-h-ambulatory blood pressure monitoring in sub-Saharan Africa: Hypertension phenotypes and dipping patterns in Malawian HIV+ patients on antiretroviral therapy. Glob. Heart 16(1), 67 (2021).
pubmed: 34692392 pmcid: 8516010 doi: 10.5334/gh.945
Kwarisiima, D. et al. Population-based assessment of hypertension epidemiology and risk factors among HIV-positive and general populations in rural Uganda. PLoS One 11(5), e0156309 (2016).
pubmed: 27232186 pmcid: 4883789 doi: 10.1371/journal.pone.0156309
Lubega, G. et al. Prevalence and factors associated with hypertension among people living with HIV/AIDS on antiretroviral therapy in Uganda. Pan Afr. Med. J. 38, 216 (2021).
pubmed: 34046122 pmcid: 8140674 doi: 10.11604/pamj.2021.38.216.28034
Malaza, A. et al. Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa. PLoS One 7(10), e47761 (2012).
pubmed: 23082211 pmcid: 3474786 doi: 10.1371/journal.pone.0047761
Manne-Goehler, J. et al. The ART advantage: Health care utilization for diabetes and hypertension in rural South Africa. J. Acquir. Immune Defic. Syndr. 75(5), 561–567 (2017).
pubmed: 28696346 pmcid: 5516957 doi: 10.1097/QAI.0000000000001445
Manne-Goehler, J. et al. Hypertension and diabetes control along the HIV care cascade in rural South Africa. J. Int. AIDS Soc. 22(3), e25213 (2019).
pubmed: 30916897 pmcid: 6436499 doi: 10.1002/jia2.25213
Mathabire Rucker, S. C. et al. High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi. AIDS 32(2), 253–260 (2018).
pubmed: 29135581 doi: 10.1097/QAD.0000000000001700
Memiah, P. et al. Hypertension and associated inflammatory markers among HIV-infected patients in Tanzania. J. Interferon Cytokine Res. 41(8), 291–301 (2021).
pubmed: 34410876 doi: 10.1089/jir.2021.0059
Muddu, M. et al. Integrated hypertension and HIV care cascades in an HIV treatment program in eastern Uganda: A retrospective cohort study. J. Acquir. Immune Defic. Syndr. 81(5), 552–561 (2019).
pubmed: 31045649 pmcid: 6625912 doi: 10.1097/QAI.0000000000002067
Mulugeta, H. et al. Incidence and predictors of hypertension among HIV patients receiving ART at public health facilities, northwest Ethiopia: A one-year multicenter prospective follow-up study. HIV AIDS (Auckl) 13, 889–901 (2021).
pubmed: 34526825
Musekwa, R. et al. Prevalence and correlates of hypertension in HIV-positive adults from the Livingstone Central Hospital, Zambia. Pan Afr. Med. J. 39, 237 (2021).
pubmed: 34659610 pmcid: 8498662 doi: 10.11604/pamj.2021.39.237.29718
Mutemwa, M. et al. Prevalence, detection, treatment, and control of hypertension in human immunodeficiency virus (HIV)-infected patients attending HIV clinics in the Western Cape Province, South Africa. Medicine (Baltimore) 97(35), e12121 (2018).
pubmed: 30170445 doi: 10.1097/MD.0000000000012121
Nduka, C. U. et al. Impact of body fat changes in mediating the effects of antiretroviral therapy on blood pressure in HIV-infected persons in a sub-Saharan African setting. Infect. Dis. Poverty 5(1), 55 (2016).
pubmed: 27245216 pmcid: 4888205 doi: 10.1186/s40249-016-0152-7
Niwaha, A. J. et al. Association between blood pressure and HIV status in rural Uganda: Results of cross-sectional analysis. Glob. Heart 16(1), 12 (2021).
pubmed: 33598392 pmcid: 7880004 doi: 10.5334/gh.858
Njelekela, M. et al. Prevalence of hypertension and its associated risk factors among 34,111 HAART naive HIV-infected adults in Dar es Salaam, Tanzania. Int. J. Hypertens. 2016, 5958382 (2016).
pubmed: 27872756 pmcid: 5107235 doi: 10.1155/2016/5958382
Odukoya, O. et al. Behavioral risk factors for hypertension among adults living with HIV accessing care in secondary health facilities in Lagos State, Nigeria. J. Fam. Med. Prim. Care 9(7), 3450–3457 (2020).
doi: 10.4103/jfmpc.jfmpc_544_20
Ogunmola, O. J., Oladosu, O. Y. & Olamoyegun, A. M. Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: A cross-sectional cohort study. Vasc. Health Risk Manag. 10, 129–137 (2014).
pubmed: 24672244 pmcid: 3964169 doi: 10.2147/VHRM.S58449
Okello, S. et al. D-Dimer levels and traditional risk factors are associated with incident hypertension among HIV-infected individuals initiating antiretroviral therapy in Uganda. J. Acquir. Immune Defic. Syndr. 73(4), 396–402 (2016).
pubmed: 27171743 pmcid: 5085880 doi: 10.1097/QAI.0000000000001074
Okello, S. et al. Incidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda. J. Hypertens. 33(10), 2039–2045 (2015).
pubmed: 26431192 pmcid: 4700387 doi: 10.1097/HJH.0000000000000657
Okello, S. et al. Blood pressure trajectories and the mediated effects of body mass index and HIV-related inflammation in a mixed cohort of people with and without HIV in rural Uganda. J. Clin. Hypertens. (Greenwich) 21(8), 1230–1241 (2019).
pubmed: 31278845 doi: 10.1111/jch.13621
Okpa, H. O. et al. Predictors of hypertension in an urban HIV-infected population at the University of Calabar Teaching Hospital, Calabar, Nigeria. HIV AIDS (Auckl) 9, 19–24 (2017).
pubmed: 28243150
Pangmekeh, P. J. et al. Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital, Cameroon. Pan Afr. Med. J. 33, 87 (2019).
pubmed: 31489065 pmcid: 6713512 doi: 10.11604/pamj.2019.33.87.15574
Pfaff, C. et al. Early experiences integrating hypertension and diabetes screening and treatment in a human immunodeficiency virus clinic in Malawi. Int. Health 10(6), 495–501 (2018).
pubmed: 30052987 doi: 10.1093/inthealth/ihy049
Rajagopaul, A. & Naidoo, M. Prevalence of diabetes mellitus and hypertension amongst the HIV-positive population at a district hospital in eThekwini, South Africa. Afr. J. Prim. Health Care Fam. Med. 13(1), e1–e6 (2021).
pubmed: 34636608 doi: 10.4102/phcfm.v13i1.2766
Rodriguez-Arboli, E. et al. Incidence and risk factors for hypertension among HIV patients in rural Tanzania—A prospective cohort study. PLoS One 12(3), e0172089 (2017).
pubmed: 28273105 pmcid: 5342176 doi: 10.1371/journal.pone.0172089
Saito, A., Karama, M. & Kamiya, Y. HIV infection, and overweight and hypertension: A cross-sectional study of HIV-infected adults in Western Kenya. Trop. Med. Health 48, 31 (2020).
pubmed: 32398924 pmcid: 7203910 doi: 10.1186/s41182-020-00215-w
Sander, L. D. et al. Hypertension, cardiovascular risk factors and antihypertensive medication utilisation among HIV-infected individuals in Rakai, Uganda. Trop. Med. Int. Health 20(3), 391–396 (2015).
pubmed: 25430847 doi: 10.1111/tmi.12443
Sarfo, F. S. et al. Characteristics of hypertension among people living with HIV in Ghana: Impact of new hypertension guideline. J. Clin. Hypertens. (Greenwich) 21(6), 838–850 (2019).
pubmed: 31125188 doi: 10.1111/jch.13561
Hyle, E. P. et al. The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: A systematic review. BMC Public Health 17(1), 954 (2017).
pubmed: 29246206 pmcid: 5732372 doi: 10.1186/s12889-017-4940-1
Abrahams, Z. et al. Changes in blood pressure, glucose levels, insulin secretion and anthropometry after long term exposure to antiretroviral therapy in South African women. AIDS Res. Ther. 12, 24 (2015).
pubmed: 26251665 pmcid: 4526419 doi: 10.1186/s12981-015-0065-8
Nzuobontane, D., Ngu, B. K. & Christopher, K. Cardiovascular autonomic dysfunction in Africans infected with human immunodeficiency virus. J. R. Soc. Med. 95(9), 445–447 (2002).
pubmed: 12205208 pmcid: 1279990 doi: 10.1177/014107680209500905
Robles, N. R. et al. Antiretroviral treatment and antihypertensive therapy. Curr. Pharm. Des. 27(40), 4116–4124 (2021).
pubmed: 34784859 doi: 10.2174/1381612827666210810090805
Nduka, C. U. et al. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: A systematic review with meta-analysis. J. Hum. Hypertens. 30(6), 355–362 (2016).
pubmed: 26446389 doi: 10.1038/jhh.2015.97
Dorjee, K. et al. Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studies. Int. J. Antimicrob. Agents 52(5), 541–553 (2018).
pubmed: 30040992 pmcid: 7791605 doi: 10.1016/j.ijantimicag.2018.07.010
Harimenshi, D. et al. Hypertension and associated factors in HIV-infected patients receiving antiretroviral treatment in Burundi: A cross-sectional study. Sci. Rep. 12(1), 20509 (2022).
pubmed: 36443478 pmcid: 9705296 doi: 10.1038/s41598-022-24997-7
Dimala, C. A. et al. Association between CD4 cell count and blood pressure and its variation with body mass index categories in HIV-infected patients. Int. J. Hypertens. 2018, 1691474 (2018).
pubmed: 29610680 pmcid: 5828536 doi: 10.1155/2018/1691474
Dillon, D. G. et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: A systematic review and meta-analysis. Int. J. Epidemiol. 42(6), 1754–1771 (2013).
pubmed: 24415610 doi: 10.1093/ije/dyt198
Nuesch, R. et al. Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). J. Acquir. Immune Defic. Syndr. 62(4), 396–404 (2013).
pubmed: 23288033 doi: 10.1097/QAI.0b013e3182847cd0
Krsak, M. et al. Myocardial infarction, stroke, and mortality in cART-treated HIV patients on statins. AIDS Patient Care STDS 29(6), 307–313 (2015).
pubmed: 25855882 pmcid: 4516911 doi: 10.1089/apc.2014.0309
Yuyun, M. F. et al. Cardiovascular diseases in sub-Saharan Africa compared to high-income countries: An epidemiological perspective. Glob. Heart 15(1), 15 (2020).
pubmed: 32489788 pmcid: 7218780 doi: 10.5334/gh.403
Deaton, A. S. & Tortora, R. People in sub-Saharan Africa rate their health and health care among the lowest in the world. Health Aff. (Millwood) 34(3), 519–527 (2015).
pubmed: 25715657 doi: 10.1377/hlthaff.2014.0798
Kivuyo, S. et al. Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): A pragmatic cluster-randomised, controlled trial. Lancet 402(10409), 1241–1250 (2023).
pubmed: 37805215 doi: 10.1016/S0140-6736(23)01573-8
Challacombe, S. J. Global inequalities in HIV infection. Oral Dis. 26(Suppl 1), 16–21 (2020).
pubmed: 32862524 doi: 10.1111/odi.13386

Auteurs

Alexander Chen (A)

Torrens University Australia, Adelaide, SA, Australia.

Yih-Kai Chan (YK)

Australian Catholic University, Melbourne, VIC, Australia.

Ana O Mocumbi (AO)

Universidade Eduardo Mondlane, Maputo, Mozambique.
Instituto Nacional de Saúde, Marracuene, Mozambique.

Dike B Ojji (DB)

Department of Internal Medicine, Faculty of Clinical Sciences, University of Abuja, Abuja, Nigeria.
Department of Medicine, Cape Heart Institute, University of Cape Town, Cape Town, South Africa.

Laura Waite (L)

Victorian Department of Health, Melbourne, VIC, Australia.

Justin Beilby (J)

Torrens University Australia, Adelaide, SA, Australia.

Jim Codde (J)

Institute for Health Research, The University of Notre Dame Australia, 32 Mouat St, Fremantle, WA, 6160, Australia.

Igor Dobe (I)

Universidade Eduardo Mondlane, Maputo, Mozambique.
Instituto Nacional de Saúde, Marracuene, Mozambique.

Benedicta Ngwenchi Nkeh-Chungag (BN)

Department of Biological and Environmental Sciences, Faculty of Natural Sciences, Walter Sisulu University, Mthatha, South Africa.

Albertino Damasceno (A)

Universidade Eduardo Mondlane, Maputo, Mozambique.

Simon Stewart (S)

Universidade Eduardo Mondlane, Maputo, Mozambique. simon.stewart@nd.edu.au.
Department of Medicine, Cape Heart Institute, University of Cape Town, Cape Town, South Africa. simon.stewart@nd.edu.au.
Institute for Health Research, The University of Notre Dame Australia, 32 Mouat St, Fremantle, WA, 6160, Australia. simon.stewart@nd.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH